1.陈家伦，陈名道.中国糖尿病调查//邝安坤，陈家伦，侯积寿.糖尿病在中国.长沙：湖南科学技术出版社，1989：47.

2.项坤三，钱荣立.NIDDM分子遗传学研究进展.中国糖尿病杂志，1996，4（1）：41.

3.逢力男.老年糖尿病//董砚虎.糖尿病及其并发症当代治疗.济南：山东科学技术出版社，1994.

4.向红丁，吴纬，刘灿群.1996年全国糖尿病流行病学特点基线调查报告.中国糖尿病杂志，1998，6（3）：131.

5.朱禧星.糖尿病//陈灏珠.实用内科学.北京：人民卫生出版社，1997：828.

6.颜纯.人组织相容抗原与胰岛素依赖型糖尿病遗传易感性研究的进展.中国糖尿病杂志，1994，2（1）：53.

7. Cassell PG，Neverova M，Janmotlamed S，et al.An uncoupling protein2gene variant is associated with a raised body mass index but not type E diabetes.Diabetologia，1999，42 （6）：688.

8. Garofano A，Czemichow P，Breant B.Effect of aging on beta-cell mass and function in rats malnourished during the perinatal period.Diabetologia，1999，42：711.

9. Hales CN，Desai M，Ozanne SE.The thrifty phenotype hypothesis：How dose it look after 5 years？Diabetic Medicine，1997，14（3）：189.

10. Tisch R，McDevitt H.Insulin dependent diabetes mellitus. Cell，1996，85（3）：291.

11. Tuomilehto J，karvonen M，Pitk Earlierni J，et al.Recordhigh incidence of typeⅠ（insulin-dependent）diabetes mellitus in Finnish children.Diabetologia，1999，42（6）：655.

12. Jackson RA，Japsan JB.Glucose intolerance and aging// Morley IE，Korenman SG.Endocrinology and metabolism in the elderly. Boston：Blackwell Scientific Publications，1992：353.

13. Hotamisligil GS.Tumor necrosis factor-uA key component of the obesity diabetes link. Diabetes，1994，43（11）：1271.

14. Pelleymounter MA，Cullen MJ，Baker MB，et al.Effect of the obese gene product on body weight regulation on ob/ ob mice.Science，1995，269（5223）：540.

15. Campfield LA，Smith FJ，Guisez Y，et al. Recombinant mouse OB protein：Evidence for a peripheral signal linking adiposity and central network. Science，1995，269 （5223）：546.

16. Ghosh S.Genetic analysis of NIDDM-the study of quantitative traits.Diabetes，1996，45（1）：1-14.

17. Bäckhed F，Ding H，Wang T，et al.The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A，2004，101：15718-15723.

18. Picard F，Kurtev M，Chung N，et al.Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature，2004，429（6993）：771-776.

19. Guarente L，Picard F.Calorie restriction-the SIR2 connection.Cell，2005，120（4）：473-482.

20. Kobayashi Y，Furukawa-Hibi Y，Chen C，et al.SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress.Int J Mol Med，2005，16（2）：237-243.

21. Rodgers JT，Lerin C，Puigserver P，et al.Nutritient control of glucose homeostasis through a complex of PGC-1 and SIRT1.Nature，2005，434：113-118.

22. Boney CM，Verma A，Tucker R，Vohr BR.Metabolic syndrome in childhood：association with birth weight，maternal obesity，and gestational diabetes mellitus.Pediatrics，2005，115（3）：e290-296.

23. Decochez K，Truyen I，van der Auwera B，et al.Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.Diabetologia.2005，48（4）：687-694.

24. Malcolm JC，Lawson ML，Gaboury I，et al.Glucose tolerance of offspring of mother with gestational diabetes mellitus in a low-risk population.Diabet Med，2006，23（5）：565-570.

25.薛京伦.表观遗传学——原理、技术与实践.上海：上海科学技术出版社，2006.

26. DIAMOND Project Group.Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999.Diabet Med，2006，23（8）：857-866.

27. Ludvigsson J.Why diabetes incidence increases-a unifying theory.Ann N Y Acad Sci，2006，1079：374-382.

28. Nguyen M，Qin FX，Tong Q.SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction.Aging Cell，2007，6（4）：505-514.

29. Sun C，Zhang F，Zhai QW，et al.SIRT1 improves insulin sensitivity under insulin resistant conditions by repressing PTP1B.Cell Metabolism，2007，6：307-319.

30. Bartsocas CS，Gerasimidi-Vazeou A.Genetics of type 1 diabetes mellitus.Pediatr Endocrinol Rev，2007，5（1）：470.

31. Wang JP，Zhou ZG，Lin J，Huang G，et al.Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives. Tissue Antigens，2007，70（5）：369-375.

32. Haller MJ，Gottlieb PA，Schatz DA.Type 1 diabetes intervention trials 2007：where are we and where are we going？Curr Opin Endocrinol Diabetes Obes，2007，14（4）：283-287.

33. Kabelitz D，Geissler EK，Soria B，et al.Toward cell-based therapy of type I diabetes.Trends Immunol，2008，29（2）：68-74.

34. Taplin CE，Barker JM.Autoantibodies in type 1 diabetes. Autoimmunity，2008，41（1）：11-18.

35. Neish AS.Microbes in gastrointestinal health and disease. Gastroenterology，2009，136：65-80.

36. Bäckhed F，Manchester JK，Semenkovich CF，et al.Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A，2007，104：979-984.

37. Turnbaugh PJ，Bäckhed F，Fulton L，et al.Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome.Cell Host Microbe，2008，3：213-223.

38. Turnbaugh PJ，Ridaura VK，Faith JJ，et al.The effect of diet on the human gut microbiome：a metagenomic analysis in humanized gnotobiotic mice.Sci Transl Med，2009，1：1-10.

39. Martin FP，Wang Y，Sprenger N，et al.Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model.Mol Syst Biol，2008，4：1-15.

40. Hildebrandt MA，Hoffmann C，Sherrill-Mix SA，et al.Highfat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology，2009，137：1716-1724.el-2.

41. Turnbaugh PJ，Ley RE，Mahowald MA，et al.An obesityassociated gut microbiome with increased capacity for energy harvest.Nature，2006，444：1027-1031.

42. Turnbaugh PJ，Hamady M，Yatsunenko T，et al. A core gut microbiome in obese and lean twins. Nature，2009，457：480-484.

43. Neyrinck AM，Cani PD，Dewulf EM，et al.Critical role of Kupffer cells in the management of diet-induced diabetes and obesity. Biochem Biophys Res Commun，2009，385：351-356.

44. Huang W，Metlakunta A，Dedousis N，et al.Depletion of liver Kupffer cells prevents the development of diet-induced hepatic stenosis and insulin resistance. Diabetes，2010，59：347-357.

45. Cani PD，Bibiloni R，Knauf C，et al.Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.Diabetes，2008，57：1470-1481.

46. Ghanim H，Abuaysheh S，Sia CL，et al.Increase in plasma endotoxin concentrations and the expression of toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat，high-carbohydrate meal：implications for insulin resistance. Diabetes Care，2009，32：2281-2287.

47. Deopurkar R，Ghanim H，Friedman J，et al. Differential effects of cream，glucose and orange juice on inflammation，endotoxin，and the expression of toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care，2010，33：991-997.

48. Cani PD，Lecourt E，Dewulf EM，et al.Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr，2009，90：1236-1243.

49. Cani PD，Possemiers S，Van de Wiele T，et al.Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.Gut，2009，58：1091-1103.

50. Luoto R，Kalliomäki M，Laitinen K，et al.The impact of perinatal probiotic intervention on the development of overweight and obesity：follow-up study from birth to 10 years.Int J Obes（Lond），2010，34（10）：1531-1537.

51. MussoG，GambinoR，CassaderM.Obesity，diabetes，and gut microbiota：the hygiene hypothesis expanded？Diabetes Care，2010，33（10）：2277-2284.

52. Kau AL，Ahern PP，Griffin NW，et al.Human nutrition，the gut microbiome and the immune system.Nature，2011，474 （7351）：327-336.

53. Delzenne NM，Neyrinck AM，Bäckhed F，et al.Nat Rev Endocrinol，2011，7（11）：639-646.

54. Tremaroli V，Bäckhed F.Functional interactions between the gut microbiota and host metabolism.Nature，2012，489 （7415）：242-249.

55. Le Roy T，Llopis M，Lepage P，et al.Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice.Gut，2012，29.［Epub ahead of print］